82 FR 25803 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 106 (June 5, 2017)

Page Range		25803-25804
FR Document		2017-11495

Federal Register, Volume 82 Issue 106 (Monday, June 5, 2017)

[Federal Register Volume 82, Number 106 (Monday, June 5, 2017)]
[Notices]
[Pages 25803-25804]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-11495]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; LTCDS Contract Review.
    Date: June 27, 2017.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 
594-8898, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; SBIR Phase II 
Exploratory Clinical Trials.
    Date: June 30, 2017.
    Time: 12:00 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Thomas A. Tatham, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-3993, [email protected].


[[Page 25804]]


    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK P01 Review.
    Date: July 18, 2017.
    Time: 4:00 p.m.to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-4719, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Program Project on 
Mucosal Immunology.
    Date: July 25, 2017.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7017, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-7637, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: May 30, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-11495 Filed 6-2-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 106 / Monday, June 5, 2017 / Notices 25803

(12 CFR 225.28) or that the Board has meeting, see the DMICC Web site, Dated: May 23, 2017.
determined by Order to be closely www.diabetescommittee.gov, or contact B. Tibor Roberts,
related to banking and permissible for Dr. B. Tibor Roberts, Executive Executive Secretary, DMICC, Office of
bank holding companies. Unless Secretary of the Diabetes Mellitus Scientific Program and Policy Analysis,
otherwise noted, these activities will be Interagency Coordinating Committee, National Institute of Diabetes and Digestive
conducted throughout the United States. National Institute of Diabetes and and Kidney Diseases, National Institutes of
Each notice is available for inspection Health.
Digestive and Kidney Diseases, 31
at the Federal Reserve Bank indicated. [FR Doc. 2017–11494 Filed 6–2–17; 8:45 am]
Center Drive, Building 31A, Room
The notice also will be available for 9A19, MSC 2560, Bethesda, MD 20892– BILLING CODE 4140–01–P
inspection at the offices of the Board of 2560, telephone: 301–496–6623; FAX:
Governors. Interested persons may 301–480–6741; email: dmicc@
express their views in writing on the DEPARTMENT OF HEALTH AND
mail.nih.gov. HUMAN SERVICES
question whether the proposal complies
with the standards of section 4 of the SUPPLEMENTARY INFORMATION: The National Institutes of Health
BHC Act. DMICC, chaired by the National
Unless otherwise noted, comments Institute of Diabetes and Digestive and National Institute of Diabetes and
regarding the applications must be Kidney Diseases (NIDDK) comprising Digestive and Kidney Diseases; Notice
received at the Reserve Bank indicated members of the Department of Health of Closed Meetings
or the offices of the Board of Governors and Human Services and other federal
not later than June 19, 2017. Pursuant to section 10(d) of the
agencies that support diabetes-related
A. Federal Reserve Bank of St. Louis Federal Advisory Committee Act, as
activities, facilitates cooperation,
(David L. Hubbard, Senior Manager) amended (5 U.S.C. App.), notice is
communication, and collaboration on hereby given of the following meetings.
P.O. Box 442, St. Louis, Missouri
diabetes among government entities. The meetings will be closed to the
63166–2034. Comments can also be sent
DMICC meetings, held several times a public in accordance with the
electronically to Comments
.applications@stls.frb.org: year, provide an opportunity for provisions set forth in sections
1. Paramount Financial Group, LLC, Committee members to learn about and 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
St. Louis, Missouri; to acquire 100 discuss current and future diabetes as amended. The grant applications and
percent of the voting shares of programs in DMICC member the discussions could disclose
Paramount Bond & Mortgage Co., Inc., organizations and to identify confidential trade secrets or commercial
St. Louis, Missouri, and thereby engage opportunities for collaboration. The property such as patentable material,
in mortgage activities pursuant to June 23, 2017 DMICC meeting will focus and personal information concerning
section 225.28(b)(1) of Regulation Y. on Measurement Science and Glycemic individuals associated with the grant
Board of Governors of the Federal Reserve
Control. applications, the disclosure of which
System, May 31, 2017. Any member of the public interested would constitute a clearly unwarranted
Yao-Chin Chao, in presenting oral comments to the invasion of personal privacy.
Assistant Secretary of the Board. Committee should notify the contact Name of Committee: National Institute of
person listed on this notice at least 10 Diabetes and Digestive and Kidney Diseases
[FR Doc. 2017–11527 Filed 6–2–17; 8:45 am]
days in advance of the meeting. Special Emphasis Panel; LTCDS Contract
BILLING CODE 6210–01–P Review.
Interested individuals and Date: June 27, 2017.
representatives or organizations should Time: 10:00 a.m. to 12:00 p.m.
DEPARTMENT OF HEALTH AND submit a letter of intent, a brief Agenda: To review and evaluate grant
HUMAN SERVICES description of the organization applications.
represented, and a written copy of their Place: National Institutes of Health, Two
National Institutes of Health oral presentation in advance of the Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
meeting. Only one representative of an Conference Call).
Notice of Diabetes Mellitus Interagency organization will be allowed to present; Contact Person: Michele L. Barnard, Ph.D.,
Coordinating Committee Meeting oral comments and presentations will be Scientific Review Officer, Review Branch,
SUMMARY: The Diabetes Mellitus limited to a maximum of 5 minutes. DEA, NIDDK, National Institutes of Health,
Interagency Coordinating Committee Printed and electronic copies are Room 7353, 6707 Democracy Boulevard,
requested for the record. In addition, Bethesda, MD 20892–2542, (301) 594–8898,
(DMICC) will hold a meeting on June 23, barnardm@extra.niddk.nih.gov.
2017. The subject of the meeting will be any interested person may file written
Name of Committee: National Institute of
‘‘Measurement Science and Glycemic comments with the Committee by
Diabetes and Digestive and Kidney Diseases
Control.’’ The meeting is open to the forwarding their statement to the Special Emphasis Panel; SBIR Phase II
public. contact person listed on this notice. The Exploratory Clinical Trials.
DATES: The meeting will be held on June statement should include the name, Date: June 30, 2017.
address, telephone number and when Time: 12:00 p.m. to 1:30 p.m.
23, 2017; from 8:30 a.m. to 4:30 p.m.
applicable, the business or professional Agenda: To review and evaluate grant
Individuals wanting to present oral applications.
comments must notify the contact affiliation of the interested person.
asabaliauskas on DSKBBXCHB2PROD with NOTICES

Place: National Institutes of Health, Two
person at least 10 days before the Because of time constraints for the Democracy Plaza, 6707 Democracy
meeting date. meeting, oral comments will be allowed Boulevard, Bethesda, MD 20892 (Telephone
ADDRESSES: The meeting will be held in on a first-come, first-serve basis. Conference Call).
the Democracy 2 Building at 6707 Members of the public who would Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
Democracy Blvd., Bethesda, MD, in like to receive email notification about DEA, NIDDK, National Institutes of Health,
Conference Room 7050. future DMICC meetings should register Room 7021, 6707 Democracy Boulevard,
FOR FURTHER INFORMATION CONTACT: For for the listserv available on the DMICC Bethesda, MD 20892–5452, (301) 594–3993,
further information concerning this Web site, www.diabetescommittee.gov. tathamt@mail.nih.gov.

VerDate Sep<11>2014 17:31 Jun 02, 2017 Jkt 241001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\05JNN1.SGM 05JNN1

25804 Federal Register / Vol. 82, No. 106 / Monday, June 5, 2017 / Notices

Name of Committee: National Institute of applications, the disclosure of which Property Office on or before June 20,
Diabetes and Digestive and Kidney Diseases would constitute a clearly unwarranted 2017 will be considered.
Special Emphasis Panel; NIDDK P01 Review. invasion of personal privacy. ADDRESSES: Requests for copies of the
Date: July 18, 2017.
Time: 4:00 p.m.to 6:30 p.m. Name of Committee: NIGMS Initial Review patent application, inquiries, and
Agenda: To review and evaluate grant Group; Training and Workforce Development comments relating to the contemplated
applications. Subcommittee—D; To review R25 Bridges to Exclusive Commercialization Patent
Place: National Institutes of Health, Two Baccalaureate and K12 IRACDA Grant License should be directed to: Peter
Democracy Plaza, 6707 Democracy applications. Soukas, Technology Transfer and Patent
Boulevard, Bethesda, MD 20892 (Telephone Date: June 22–23, 2017. Specialist, Technology Transfer and
Conference Call). Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
Intellectual Property Office, National
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch, applications. Institute of Allergy and Infectious
DEA, NIDDK, National Institutes of Health, Place: Hotel Palomar, 2121 P Street NW., Diseases, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard, Washington, DC 20037. 5601 Fishers Lane, Suite 6D, Rockville,
Bethesda, MD 20892–5452, (301) 594–4719, Contact Person: Rebecca H. Johnson, Ph.D., MD 20852–9804; Email: ps193c@
guox@extra.niddk.nih.gov. Scientific Review Officer, Office of Scientific nih.gov; Telephone: (301) 594–8730;
Name of Committee: National Institute of Review, National Institute of General Medical Facsimile: (240) 627–3117.
Diabetes and Digestive and Kidney Diseases Sciences, National Institutes of Health,
SUPPLEMENTARY INFORMATION:
Special Emphasis Panel; Program Project on Natcher Building, Room 3AN18C, Bethesda,
Mucosal Immunology. MD 20892, 301–594–2771, johnsonrh@ Intellectual Property
Date: July 25, 2017. nigms.nih.gov.
E–357–2001/0,1, Pletnev et al.,
Time: 12:00 p.m. to 3:00 p.m. (Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant Program Nos. 93.375, Minority Biomedical
‘‘Construction of West Nile Virus and
applications. Research Support; 93.821, Cell Biology and Dengue Virus Chimeras for use in a Live
Place: National Institutes of Health, Two Biophysics Research; 93.859, Pharmacology, Virus Vaccine to Prevent Disease Cause
Democracy Plaza, 6707 Democracy Physiology, and Biological Chemistry by West Nile Virus,’’ U.S. Provisional
Boulevard, Bethesda, MD 20892 (Telephone Research; 93.862, Genetics and Patent Application Number 60/347,281,
Conference Call). Developmental Biology Research; 93.88, filed January 10, 2002, PCT Patent
Contact Person: Maria E. Davila-Bloom, Minority Access to Research Careers; 93.96, Application Number PCT/US2003/
Ph.D., Scientific Review Officer, Review Special Minority Initiatives; 93.859, 00594, filed January 9, 2003, U.S. Patent
Branch, DEA, NIDDK, National Institutes of Biomedical Research and Research Training,
Health, Room 7017, 6707 Democracy Application Number 10/871,775 filed
National Institutes of Health, HHS)
Boulevard, Bethesda, MD 20892–5452, (301) June 18, 2004 (now U.S. Patent Number
594–7637, davila-bloomm@ Dated: May 30, 2017. 8,778,671), U.S. Patent Application
extra.niddk.nih.gov. David Clary, Number 14/305,572, filed June 16, 2014,
(Catalogue of Federal Domestic Assistance Program Analyst, Office of Federal Advisory European Patent Application Number
Program Nos. 93.847, Diabetes, Committee Policy. 03729602.7, filed January 9, 2003,
Endocrinology and Metabolic Research; [FR Doc. 2017–11498 Filed 6–2–17; 8:45 am] Israeli Patent Application Number
93.848, Digestive Diseases and Nutrition BILLING CODE 4140–01–P 162949, filed January 9, 2003 (now
Research; 93.849, Kidney Diseases, Urology Israeli Patent Number 162949),
and Hematology Research, National Institutes Canadian Patent Application Number
of Health, HHS)
DEPARTMENT OF HEALTH AND 2472468, filed January 9, 2003 (now
Dated: May 30, 2017. HUMAN SERVICES Canadian Patent Number 2472468),
David Clary, Australian Patent Application Number
Program Analyst, Office of Federal Advisory National Institutes of Health 2003216046, filed January 9, 2003 (now
Committee Policy. Australian Patent Number 2003216046),
Prospective Grant of Exclusive Patent
[FR Doc. 2017–11495 Filed 6–2–17; 8:45 am] Japanese Patent Application Number
License: Production of Attenuated
BILLING CODE 4140–01–P 2003–559545, filed January 9, 2003
West Nile Virus Vaccines
(now Japanese Patent Number 4580650),
AGENCY: National Institutes of Health, Australian Patent Application Number
DEPARTMENT OF HEALTH AND Department of Health and Human 2008203442 filed July 31, 2008 (now
HUMAN SERVICES Services. Australian Patent Number 2008203442),
ACTION: Notice. Israeli Patent Application Number
National Institutes of Health 209342, filed January 9, 2003 (now
SUMMARY: The National Institute of Israeli Patent Number 209342),
National Institute of General Medical Allergy and Infectious Diseases, an European Patent Application Number
Sciences; Notice of Closed Meeting institute of the National Institutes of 11000126.0, filed January 9, 2003 (now
Pursuant to section 10(d) of the Health, Department of Health and European Patent Number 2339011,
Federal Advisory Committee Act, as Human Services, is contemplating the validated in Belgium, Great Britain, the
amended (5 U.S.C. App.), notice is grant of an Exclusive Commercialization Netherlands, Norway, Germany,
hereby given of the following meeting. Patent License to practice the inventions Denmark and France), Australian Patent
The meeting will be closed to the embodied in the Patents and Patent Application Number 2011250694, filed
Applications listed in the Summary
asabaliauskas on DSKBBXCHB2PROD with NOTICES

public in accordance with the November 10, 2011 (now Australian
provisions set forth in sections Information section of this notice to the Patent Number 2011250694), Australian
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., International Medica Foundation Patent Application Number
as amended. The grant applications and located in Shoreview, Minnesota, U.S.A. 2013213749, filed August 9, 2013,
the discussions could disclose DATES: Only written comments and/or European Patent Application Number
confidential trade secrets or commercial applications for a license which are 15163537.2, filed April 14, 2015, and
property such as patentable material, received by the National Institute of Canadian Patent Application Number
and personal information concerning Allergy and Infectious Diseases’ 2903126, filed August 27, 2015, and
individuals associated with the grant Technology Transfer and Intellectual U.S. and foreign patent applications

VerDate Sep<11>2014 17:31 Jun 02, 2017 Jkt 241001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\05JNN1.SGM 05JNN1

Document Created: 2018-11-14 10:00:46
Document Modified: 2018-11-14 10:00:46

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 27, 2017.
FR Citation		82 FR 25803

82 FR 25803 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 106 (June 5, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health